Table 1.
Characteristics of populations and interventions of included studies
| Trial | Level of albuminuria | Type of diabetes | Hypertension at baseline | Blood pressure equalised | Intervention* | No of patients | Follow up (months) |
|---|---|---|---|---|---|---|---|
| ACE inhibitors v placebo or no treatment:
|
|
|
|
|
|
|
|
| Estacio and Schrier (ABCD) 1998†w1 | Mixed | 2 | Yes | Yes | Enalapril 5-40 mg/d‡ | 246 | 63.6 |
| Ahmad et al 1997w3 | Microalbuminuria | 2 | — | Yes | Enalapril 10 mg/d‡ | 103 | 60 |
| Ahmad et al 2003w4 w5 | Microalbuminuria | 1 | — | Yes | Enalapril 10 mg/d‡ | 73 | 60 |
| O'Hare et al (ATLANTIS) 2000†w6 | Microalbuminuria | 1 | — | — | Ramipril 1.25 mg/d‡ | 134 | 24 |
| Bakris et al 1994w7 | Microalbuminuria | 1 | — | — | Lisinopril 78 (SD 8) mg/d | 15 | 18 |
| Bauer et al 1992w8 | Macroalbuminuria | Mixed | Yes | Yes | Enalapril 5-40 mg/d‡ | 33 | 18 |
| Bojestig et al 2001w9 | Microalbuminuria | 1 | — | — | Ramipril 1.25 mg/d v ramipril 5.0 mg/d | 55 | 24 |
| Capek et al 1994w10 | Microalbuminuria | 2 | Yes | — | Captopril 37.5 mg/d | 15 | 12 |
| Carella et al 1999w11 | Microalbuminuria | 1 | — | Yes | Fosinopril 10 mg/d‡ | 16 | 24 |
| Chase et al 1993w12 | Microalbuminuria | 1 | — | — | Captopril 50 mg twice daily | 16 | 24 |
| Cordonnier et al 1999w13 | Macroalbuminuria | 2 | Yes | Yes | Perindopril 4 mg/d† | 22 | 24 |
| Crepaldi et al 1998†w14 | Microalbuminuria | 1 | — | — | Lisinopril 2.5-20 mg/d | 96 | 36 |
| Baines (ESPRIT) 2001w15 | Mixed | 1 | — | Yes | Enalapril 10-20 mg/d | 33 | 36 |
| EUCLID Study Group 1997w16 | Mixed | 1 | — | — | Lisinopril 10-20 mg/d | 530 | 24 |
| Garg et al 1998†w18 | Microalbuminuria | 1 | — | — | Ramipril 5 mg/d | 11 | 12 |
| Hansen et al 1994w19 | Microalbuminuria | 1 | Yes | — | Captopril 50 mg twice daily | 22 | 24 |
| Jerums et al 2001†w21 | Microalbuminuria | 1 | — | — | Perindopril 2-8 mg/d | 23 | 36 |
| Katayama et al 2002†w22 | Microalbuminuria | 1 | Yes | Yes | Captopril 37.5 mg/d; imidapril 5 mg/d‡ | 79 | 18 |
| Laffel et al 1995w23 | Microalbuminuria | 1 | — | Yes | Captopril 50 mg twice daily‡ | 143 | 24 |
| Lebovitz et al 1994w24 | Mixed | 2 | Yes | Yes | Enalapril 5-40 mg/d† | 121 | 36 |
| Lewis et al 1993w25 | Macroalbuminuria | 1 | Yes | Yes | Captopril 25 mg three times daily‡ | 409 | 36 |
| Marre et al 1987w26 | Microalbuminuria | Mixed | Enalapril 20 mg/d | 20 | 6 | ||
| Maschio et al 1996w29 | Macroalbuminuria | 2 | Yes | Yes | Benazepril 10 mg/d‡ | 21 | 36 |
| Mathiesen et al 1999w30 | Macroalbuminuria | 1 | — | — | Captopril 100 mg/d | 45 | 48 |
| Micro-HOPE 2000w33 | Microalbuminuria | Mixed | Yes | — | Ramipril 10 mg/d‡ | 1140 | 54 |
| Nankervis et al 1998w35 | Microalbuminuria | Mixed | Yes | Yes | Perindopril 4 mg/d‡ | 31 | 36 |
| O'Donnell et al 1993w36 | Microalbuminuria | Mixed | — | Yes | Lisinopril 10 mg/d‡ | 32 | 12 |
| Parving et al 1989w37 | Macroalbuminuria | 1 | — | — | Captopril 25-100 mg/d | 33 | 12 |
| Parving et al 2001w38 w39 | Macroalbuminuria | 1 | — | — | Captopril 74 mg/d | 33 | 96 |
| Phillips et al 1993w40 | Mixed | 1 | Yes | — | Cilazapril 2.5-5 mg/d | 25 | 24 |
| Poulsen et al 2001w41 w42 | Microalbuminuria | 1 | Yes | — | Lisinopril 20 mg/d | 57 | 24 |
| Ravid et al 1993w43 w45 | Microalbuminuria | 2 | — | Yes | Enalapril 10 mg/d‡ | 94 | 60 |
| Romero et al 1993w47 | Microalbuminuria | 2 | — | — | Captopril 25 mg/d | 26 | 6 |
| Sano et al 1994w48 | Microalbuminuria | 2 | Yes | Yes | Enalapril 5 mg/d‡ | 52 | 48 |
| Stornello et al 1992w51 | Macroalbuminuria | 2 | Yes | — | Enalapril 5 mg/d | 24 | 6 |
| Trevisan and Tiengo 1995w52 | Microalbuminuria | 2 | Yes | — | Ramipril 1.25 mg/d | 122 | 6 |
| ACE inhibitors v AIIRAs: | |||||||
| Lacourciere et al 2000w53 | Microalbuminuria | 2 | Yes | Yes | Enalapril 5-10 mg/d v Iosartan 50 mg/d‡ | 92 | 12 |
| Tutuncu et al 2001w54 | Microalbuminuria | 2 | — | — | Enalapril 5 mg/d v Iosartan 50 mg/d | 24 | 12 |
| Muirhead et al 1989w55 | Microalbuminuria | 2 | Yes | — | Captopril 25 mg three times daily v valsartan 80 mg/d v valsartan 160 mg/d v placebo‡ | 90 | 13 |
| AIIRA v placebo or no treatment:
|
|
|
|
|
|
|
|
| Brenner et al 2001w56 | Macroalbuminuria | 2 | Yes | Yes | Losartan 50-100 mg/d‡ | 1513 | 40.8 |
| Lewis et al 2001w57 | Macroalbuminuria | 2 | Yes | Yes | Irbesartan 75-300 mg/d‡ | 1148 | 30 |
| Parving et al 2001w58 | Microalbuminuria | 2 | Yes | Yes | Irbesartan 150-300 mg/d‡ | 590 | 24 |
| Tan et al 2002w59 | Microalbuminuria | 2 | Yes | — | Losartan 50 mg/d‡ | 80 | 6 |
ACE=angiotensin converting enzyme; AIIRA=angiotensin II receptor anatagonist.
Control arm indicated if different from placebo or no treatment.
Included placebo or no treatment control arm along with additional treatment arm (non-ACE inhibitor, non-AIIRA).
Cointerventions: calcium channel blockers, β blockers, α blockers, or diuretics.